메뉴 건너뛰기




Volumn 26, Issue 9, 2012, Pages 2135-2141

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

Author keywords

CD138; multiple myeloma; progenitor cells

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CELL MARKER; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 2 RECEPTOR GAMMA C; SYNDECAN 1; UNCLASSIFIED DRUG;

EID: 84865862858     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.80     Document Type: Article
Times cited : (63)

References (28)
  • 2
    • 42449114035 scopus 로고    scopus 로고
    • Multiple myeloma
    • Kyle RA, Rajkumar SV. Multiple myeloma. Blood 2008; 111: 2962-2972.
    • (2008) Blood , vol.111 , pp. 2962-2972
    • Kyle, R.A.1    Rajkumar, S.V.2
  • 3
    • 0026786675 scopus 로고
    • Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation
    • Bakkus MH, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326-2335.
    • (1992) Blood , vol.80 , pp. 2326-2335
    • Bakkus, M.H.1    Heirman, C.2    Van Riet, I.3    Van Camp, B.4    Thielemans, K.5
  • 4
    • 0029077309 scopus 로고
    • Myeloma Ig heavy chain v region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity
    • Vescio RA, Cao J, Hong CH, Lee JC, Wu CH, Der Danielian M et al. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. J Immunol 1995; 155: 2487-2497.
    • (1995) J Immunol , vol.155 , pp. 2487-2497
    • Vescio, R.A.1    Cao, J.2    Hong, C.H.3    Lee, J.C.4    Wu, C.H.5    Der Danielian, M.6
  • 5
    • 0030614775 scopus 로고    scopus 로고
    • Myeloma V(L) and V(H) gene sequences reveal a complementary imprint of antigen selection in tumor cells
    • Sahota SS, Leo R, Hamblin TJ, Stevenson FK. Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 1997; 89: 219-226. (Pubitemid 26428196)
    • (1997) Blood , vol.89 , Issue.1 , pp. 219-226
    • Sahota, S.S.1    Leo, R.2    Hamblin, T.J.3    Stevenson, F.K.4
  • 6
    • 0026552179 scopus 로고
    • Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules
    • Pilarski LM, Jensen GS. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 1992; 6: 297-322.
    • (1992) Hematol Oncol Clin North Am , vol.6 , pp. 297-322
    • Pilarski, L.M.1    Jensen, G.S.2
  • 7
    • 0028908877 scopus 로고
    • In multiple myeloma, clonotypic B lymphocytes are detectable among CD19 + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain
    • Bergsagel PL, Smith AM, Szczepek A, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19 + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood 1995; 85: 436-447.
    • (1995) Blood , vol.85 , pp. 436-447
    • Bergsagel, P.L.1    Smith, A.M.2    Szczepek, A.3    Mant, M.J.4    Belch, A.R.5    Pilarski, L.M.6
  • 8
    • 0030049654 scopus 로고    scopus 로고
    • Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells
    • Chen BJ, Epstein J. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood 1996; 87: 1972-1976. (Pubitemid 26068913)
    • (1996) Blood , vol.87 , Issue.5 , pp. 1972-1976
    • Chen, B.J.1    Epstein, J.2
  • 9
    • 0036240724 scopus 로고    scopus 로고
    • The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment
    • DOI 10.1080/10428190290021524
    • Rasmussen T, Jensen L, Johnsen HE. The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment. Leuk Lymphoma 2002; 43: 1075-1077. (Pubitemid 34460893)
    • (2002) Leukemia and Lymphoma , vol.43 , Issue.5 , pp. 1075-1077
    • Rasmussen, T.1    Jensen, L.2    Johnsen, H.E.3
  • 10
    • 0017785769 scopus 로고
    • Primary bioassay of human tumor stem cells
    • Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461-463.
    • (1977) Science , vol.197 , pp. 461-463
    • Hamburger, A.W.1    Salmon, S.E.2
  • 16
    • 53449085087 scopus 로고    scopus 로고
    • A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma
    • Kirshner J, Thulien KJ, Martin LD, Debes Marun C, Reiman T, Belch AR et al. A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood 2008; 112: 2935-2945.
    • (2008) Blood , vol.112 , pp. 2935-2945
    • Kirshner, J.1    Thulien, K.J.2    Martin, L.D.3    Debes Marun, C.4    Reiman, T.5    Belch, A.R.6
  • 17
    • 78349284733 scopus 로고    scopus 로고
    • Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma
    • Reid S, Yang S, Brown R, Kabani K, Aklilu E, Ho PJ et al. Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma. Int J Lab Hematol 2010; 32: 190-196.
    • (2010) Int J Lab Hematol , vol.32 , pp. 190-196
    • Reid, S.1    Yang, S.2    Brown, R.3    Kabani, K.4    Aklilu, E.5    Ho, P.J.6
  • 19
    • 0034142369 scopus 로고    scopus 로고
    • Myeloma progenitors in the blood of patients with aggressive or minimal disease: Engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCD mice
    • Pilarski LM, Hipperson G, Seeberger K, Pruski E, Coupland RW, Belch AR. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood 2000; 95: 1056-1065. (Pubitemid 30062731)
    • (2000) Blood , vol.95 , Issue.3 , pp. 1056-1065
    • Pilarski, L.M.1    Hipperson, G.2    Seeberger, K.3    Pruski, E.4    Coupland, R.W.5    Belch, A.R.6
  • 21
    • 0032532608 scopus 로고    scopus 로고
    • Primary myeloma cells growing in SCID-hu mice: A model for studying the biology and treatment of myeloma and its manifestations
    • Yaccoby S, Barlogie B, Epstein J. Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood 1998; 92: 2908-2913. (Pubitemid 28469106)
    • (1998) Blood , vol.92 , Issue.8 , pp. 2908-2913
    • Yaccoby, S.1    Barlogie, B.2    Epstein, J.3
  • 22
    • 0033570946 scopus 로고    scopus 로고
    • The proliferative potential of myeloma plasma cells manifest in the SCID-hu host
    • Yaccoby S, Epstein J. The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood 1999; 94: 3576-3582. (Pubitemid 29536154)
    • (1999) Blood , vol.94 , Issue.10 , pp. 3576-3582
    • Yaccoby, S.1    Epstein, J.2
  • 23
    • 8844264524 scopus 로고    scopus 로고
    • The SCID-rab model: A novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    • DOI 10.1038/sj.leu.2403513
    • Yata K, Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia 2004; 18: 1891-1897. (Pubitemid 39530021)
    • (2004) Leukemia , vol.18 , Issue.11 , pp. 1891-1897
    • Yata, K.1    Yaccoby, S.2
  • 26
    • 77953229444 scopus 로고    scopus 로고
    • Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells
    • Fuhler GM, Baanstra M, Chesik D, Somasundaram R, Seckinger A, Hose D et al. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells. Exp Cell Res 2010; 316: 1816-1828.
    • (2010) Exp Cell Res , vol.316 , pp. 1816-1828
    • Fuhler, G.M.1    Baanstra, M.2    Chesik, D.3    Somasundaram, R.4    Seckinger, A.5    Hose, D.6
  • 27
    • 79955974540 scopus 로고    scopus 로고
    • Lenalidomide targets clonogenic side population in multiple myeloma: Pathophysiologic and clinical implications
    • Jakubikova J, Adamia S, Kost-Alimova M, Klippel S, Cervi D, Daley JF et al. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood 2011; 117: 4409-4419.
    • (2011) Blood , vol.117 , pp. 4409-4419
    • Jakubikova, J.1    Adamia, S.2    Kost-Alimova, M.3    Klippel, S.4    Cervi, D.5    Daley, J.F.6
  • 28
    • 41349095228 scopus 로고    scopus 로고
    • Inhibition of notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy
    • DOI 10.1182/blood-2007-07-102632
    • Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008; 111: 2220-2229. (Pubitemid 351451536)
    • (2008) Blood , vol.111 , Issue.4 , pp. 2220-2229
    • Nefedova, Y.1    Sullivan, D.M.2    Bolick, S.C.3    Dalton, W.S.4    Gabrilovich, D.I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.